As we close out 2024, we at OCRA are reflecting on a year of powerful advocacy and immense gratitude. Your passion and commitment to raising awareness, driving policy change, and pushing for progress for the ovarian and gynecologic cancer community have left a mark that will be felt for years to come. Here are some … Continued
“To improve patient outcomes – and quality of life – we must minimize roadblocks for access to cancer screenings that could change the course of a diagnosis. The time is now. We are urging Congressional action this week to enact this legislation into law.” The Ovarian Cancer Research Alliance today released the following statement regarding … Continued
OCRA recently joined the Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT), which is working to ensure genetic testing access for all who may carry inherited mutations that increase the risk of ovarian and other cancers. The coalition, which includes patient advocacy and industry members, endeavors to drive changes in cancer-related genetic testing policies to expand … Continued
International Forum on Ovarian Cancer Aims to Accelerate Progress Ovarian Cancer Research Alliance (OCRA) President and CEO Audra Moran, along with members of the OCRA team, joined leading scientists and non-profit executives from across the globe this October at the Helene Harris Memorial Trust (HHMT) International Forum on Ovarian Cancer. This prestigious conference, organized by … Continued
Closing out 2024 and Looking Ahead to 2025 As we approach the close of this year’s legislative calendar, the urgency surrounding the federal budget process cannot be overstated. If action is not taken before December 20, the federal government will shut down. At OCRA, we understand that every dollar allocated to cancer research represents hope … Continued
We are weeks away from election day and there is still work to be done! With Congress in recess until after the election, there is a short window of time to make things happen before the end of the year. Right now, the Multi-Cancer Early Detection Act (MCED) and the 2025 appropriations process are among … Continued
The Clearity Foundation Joins The OCRA Family A Special Message from OCRA’s President & CEO Dear OCRA Community, Earlier this week, we shared some exciting news as we close out Ovarian Cancer and Gynecologic Cancer Awareness Month. OCRA is joining forces with The Clearity Foundation, further strengthening our commitment to supporting the ovarian and entire … Continued
September is Ovarian & Gynecologic Cancer Awareness Month, and despite some uncertainties on Capitol Hill in the leadup to the election, there is a lot going on at OCRA this month. We hope you tune in to our Advocacy Update at OCRA’s online conference to learn about the vital work OCRA’s advocates are performing on … Continued
Help OCRA Make an Impact for Ovarian Cancer and Gynecologic Cancer Awareness Month September is Ovarian Cancer Awareness Month and Gynecologic Cancer Awareness Month. As the largest non-profit in the world combating ovarian and gynecologic cancers, OCRA is committing to raise $300,000 this September to accelerate progress in research, advocate for our community, and continue … Continued
Last month, we updated you on the U.S. House of Representatives’ progress on FY2025 appropriations bills, which mostly held good news for programs related to ovarian cancer funding. Those programs all either maintained their current funding level or received small increases. The Senate also took action, but so far, none of the 12 appropriations bills … Continued
Last month, we updated you on recent reports indicating that the House Committee on Appropriations was considering significant cuts to health-related programs, sparking concerns that these potential cuts could impair the efforts that OCRA and our advocates have fought for over the years. Since then, the House Committee report for Labor, Health and Human Services, … Continued
June is Uterine Cancer Awareness Month and OCRA is dedicated to fighting on behalf of not only the ovarian cancer community but the entire gynecologic cancer community. Uterine cancer is the most common gynecologic cancer in high-income countries, and around 90% of uterine cancers are endometrial cancer types — one of the few cancers experiencing … Continued
Get email updates about research news, action alerts, and ways to join the fight.
